Fourth Quarter Fiscal 2025 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $55.0 million, compared to $49.3 million, an increase of approximately 12%Gross loss of $(6.6) million, compared to $(10.9) million, a decrease of approximately 39%Loss from operations of $(28.3) million, compared with $(41.0) million, a decrease of approximately 31%Net loss per share attributable to common stockholders was $(0.85), compared with $(2.21)Backlog of $1.19 billion, compared to $1.16 billion ...

18 DECEMBER 2025 NORTHERN 3 VCT PLC ISSUE OF SUPPLEMENTARY PROSPECTUS Further to the announcement made by Northern 3 VCT PLC (“the Company”) on 8 December 2025 in conjunction with Northern Venture Trust PLC and Northern 2 VCT PLC, in respect of the offers of new ordinary shares for subscription in the 2025/26 tax year, the Company has today published a supplementary prospectus (the "Supplementary Prospectus"). The Supplementary Prospectus refers to the increase in the size of its offer (inclusive of alre ...

MONTREAL, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA®, a white uniform cream containing 0.05 mg/g of calcipotriol (CAL) and 0.5 mg/g of betamethasone dipropionate (BDP), indicated for the topical treatment of psoriasis vulgaris in adults and adolescents aged 12-17 years for up to 8 weeks.1 Knight obtained the Canadian rights to WYNZORA® through its June 202 ...

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, today announces its fiscal fourth quarter and full year audited 2025 financial results. All financial references are in Canadian Dollars unless specified otherwise. Readers are encouraged to review the Company’s September 30, 2025 full year audited financial statements and management’s dis ...

Core Insights - Terra Innovatum Global has been recognized for its thought leadership and commitment to sustainability, receiving a Special Mention for Sustainability at the 2025 UNCA Awards Gala [1][4] Company Overview - Terra Innovatum Global N.V. is a developer of micro-modular nuclear reactors, specifically the SOLO™ Micro-Modular Reactor, which aims to provide clean, affordable, and resilient baseload energy [3][7] - The SOLO™ reactor is designed to be deployable anywhere, starting at just 1 MWe, and can scale from 1 MWe to over 1 GW, facilitating the replacement of fossil-fuel plants [3][9] Technological Innovation - The SOLO™ reactor combines modularity, safety-by-design, and rapid deployability, enabling a new model for clean energy infrastructure that supports both developed and underserved regions [3][4] - It is engineered to provide a wide range of applications, including electricity, heating, cooling, water desalination, and the production of medical radioisotopes [9] Market Position and Future Plans - Terra Innovatum is fully funded with $131 million to deliver its first reactor, with regulatory approval targeted for late 2027 and commercialization expected in 2028 [4] - The company aims to address global energy shortages and promote energy equity, aligning its mission with the Sustainable Development Goals [4][8] Strategic Importance - The SOLO™ reactor is positioned to support critical infrastructure and enhance national resilience, particularly in the aftermath of natural disasters [3][4] - By providing reliable access to clean energy, the company contributes to economic growth, healthcare, education, and climate action, which are foundational to long-term community development [4][9]

Core Points - Kane Biotech Inc. has completed a non-brokered private placement offering of common shares, issuing 14,000,000 shares at a price of $0.05 per share, resulting in gross proceeds of $700,000 [2] - The net proceeds from the offering will be allocated for working capital and general corporate purposes [2] - The transaction is classified as a "related party transaction" under Multilateral Instrument 61-101, and the company is exempt from formal valuation and minority approval requirements [3] Company Overview - Kane Biotech is focused on developing innovative wound care treatments that target biofilms, which contribute to antibiotic resistance in wounds, leading to serious clinical outcomes and high costs [5] - The company's products, including revyve® Antimicrobial Wound Gel and revyve® Antimicrobial Wound Gel Spray, have received US FDA 510(k) clearance and Health Canada approval [5]

The financial calendar for Schouw & Co. for 2026 is as follows: 5 March 2026Release of Annual Report 202516 April 2026Annual General Meeting21 April 2026Expected payment of dividend for 20251 May 2026Release of Q1 2026 interim report14 August 2026Release of Q2 2026 interim report6 November 2026Release of Q3 2026 interim report Resolution proposals from shareholders to be considered at the annual general meeting to be held on 16 April 2026 must be received by the company on or before Wednesday, 4 March 2026 ...

Core Viewpoint - CTO Realty Growth, Inc. has announced the acquisition of Pompano Citi Centre for $65.2 million, marking its first entry into the Fort Lauderdale market and expanding its footprint in Florida [1][3]. Group 1: Acquisition Details - The Pompano Citi Centre consists of 509,000 square feet of operating space, currently 92% occupied, and includes 62,000 square feet of unfinished shell space for future leasing opportunities [2]. - The property is anchored by major retailers such as Burlington, TJ Maxx, Nordstrom Rack, Ross Dress for Less, and J.C. Penney, and is located at a high-traffic intersection, enhancing visibility and access [2]. - The surrounding area has a robust demographic profile, with an average household income of $105,000 and a population exceeding 250,000 within a five-mile radius [2]. Group 2: Strategic Implications - The acquisition is expected to create long-term value through strategic mark-to-market rent opportunities and incremental leasing [3]. - This transaction is accretive to an anticipated property disposition, bringing the year-to-date investment volume to $149.9 million [3]. Group 3: Company Overview - CTO Realty Growth, Inc. specializes in owning and operating high-quality, open-air shopping centers in high-growth markets in the Southeast and Southwest United States [4]. - The company also manages and holds a significant interest in Alpine Income Property Trust, Inc. [4].

Core Viewpoint - INNO HOLDINGS INC. has announced a 1-for-24 reverse stock split to comply with Nasdaq listing requirements and strengthen its capital structure [1][4]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of issued and outstanding shares from approximately 97,948,480 to about 4,081,187 shares [3]. - The reverse stock split will take effect on December 22, 2025, at 12:01 a.m. Eastern Time, and the common stock will continue to trade under the symbol "INHD" on a split-adjusted basis [2][3]. - Fractional shares will not be issued; instead, any fractional entitlements will be rounded up to the next highest whole number [3]. Group 2: Company Overview - INNO HOLDINGS INC. is a trade-focused electronic products trading company incorporated in Texas, with operations primarily in Hong Kong [5]. - The company aims to enhance its enterprise value and shareholder value by creating greater commercial value for its business partners [5]. - INNO has a professional brand and marketing management system to facilitate the connection and operation of marketing channels globally [5].

Core Viewpoint - Aktieselskabet Schouw & Co. has announced a new share buy-back programme of up to DKK 240 million, set to run from January 2, 2026, to December 31, 2026, replacing the previous programme that was fully executed by December 12, 2025 [1][2]. Group 1: Share Buy-Back Programme Details - The new share buy-back programme is authorized by the Board of Directors based on a resolution from the annual general meeting held on April 10, 2025, allowing the company to acquire treasury shares up to 20% of its total share capital [2]. - Currently, Schouw & Co. holds 2,242,793 treasury shares, which is 8.97% of the share capital, and under the new authorization, it can acquire an additional 2,757,207 treasury shares, totaling 11.03% of the share capital [2]. - The buy-back will comply with Regulation (EU) No. 596/2014 on market abuse and the Commission's delegated regulation (EU) 2016/1052, which outlines "Safe Harbour" rules [3]. Group 2: Purpose and Management - The primary purpose of the share buy-back programme is to reduce the company's share capital [4]. - Schouw & Co. has appointed Nordea as the lead manager for the programme, which will operate independently in making trading decisions without influence from Schouw & Co. [5]. - The company reserves the right to suspend or terminate the programme at any time, with such decisions to be disclosed in a company announcement [5]. Group 3: Reporting and Transparency - Schouw & Co. will provide weekly announcements regarding the transactions conducted under the share buy-back programme [6].